Shuttle Pharmaceuticals Holdings Inc
SHPH
NASDAQ
Biotechnology
$4.07
USD
-0.51 (-11.14%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $2.92M
Volume 44.4K
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$-10.82M
TTM
-3.4%
YoY
Operating Cash Flow
$-9.37M
TTM
-8.8%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 0.6 | 2.3 | 0.9 | 1.8 | 1.2 |
Other Operating Expenses | 0.8 | 0.5 | 0.4 | 0.4 | 0.8 |
Total Operating Expenses | 3.0 | 3.9 | 2.3 | 2.8 | 2.2 |
Operating Income | -3.0 | -3.9 | -2.3 | -2.8 | -2.2 |
EBITDA | -2.2 | -3.4 | -1.8 | -2.1 | -0.8 |
Other Income / Expense | -0.1 | 0.2 | -0.1 | 0.2 | 0.1 |
Total Other Income / Expense | -0.1 | 0.2 | -0.1 | 0.2 | 0.1 |
Income Before Income Taxes | -3.1 | -3.7 | -2.3 | -2.6 | -2.2 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -3.1 | -3.7 | -2.3 | -2.6 | -2.2 |
Consolidated Net Income / Loss | -3.1 | -3.7 | -2.3 | -2.6 | -2.2 |
Net Income Attributable to Common Shareholders | -3.1 | -3.7 | -2.3 | -2.6 | -2.2 |
Basic EPS | -$76.00 | -$32.90 | -$10.50 | -$9.37 | -$4.30 |
Diluted EPS | -$76.00 | -$32.90 | -$10.50 | -$9.37 | -$4.30 |
Basic Shares Outstanding | 0.0M | 0.1M | 0.2M | 0.3M | 0.5M |
Diluted Shares Outstanding | 0.0M | 0.1M | 0.2M | 0.3M | 0.5M |